Iktos and Curreio Announce Collaboration Agreement in New Drug Discovery

French AI company Iktos and Japanese firm Curreio have announced a collaboration agreement in the field of new drug discovery, combining generative design technology with cryo-electron microscopy platform to speed up and reduce costs associated with preclinical drug candidate creation for an undisclosed target. Under the agreement, Iktos’ Makya generative AI technology will be used alongside str..